Short term pretreatment with medroxyprogesterone and testosterone may potentiate irradiation damage to spermatogenesis in rats

Cancer

Volumn 85, Issue 6, 1999, Pages 1313-1322

  Es Slami, Samira ^a   Charcellay, Sébastien ^a   Pinon Lataillade, Ghislaine ^b   Soufir, Jean Claude ^a  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

Author keywords

Cancer therapy; Fertility; Irradiation; Medroxyprogesterone and testosterone; Testis

Indexed keywords

MEDROXYPROGESTERONE; TESTOSTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HORMONAL THERAPY; LIPID PEROXIDATION; MALE; MALE FERTILITY; MALE INFERTILITY; MATING; NONHUMAN; PRIORITY JOURNAL; RADIATION INJURY; RAT; SPERMATOGENESIS; SPERMATOZOON COUNT; TESTIS WEIGHT;

ANIMALS; EPIDIDYMIS; FEMALE; FERTILITY; FETUS; MALE; MEDROXYPROGESTERONE; ORGAN SIZE; PREGNANCY; RADIATION DOSAGE; RADIATION INJURIES, EXPERIMENTAL; RADIATION-PROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; SPERMATOGENESIS; TESTIS; TESTOSTERONE;

EID: 0033559683     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19990315)85:6<1313::AID-CNCR14>3.0.CO;2-K     Document Type: Article

References (43)

1. Waxman J. Cancer, chemotherapy, and fertility. Br Med J 1985;290:1096-7.
2. Robbins WA, Meistrich ML, Moore D, Hagemeister FB, Weier HU, Cassel MJ, et al. Chemotherapy induces transient sex chromosomal and autosomal aneuploidy in human sperm. Nat Genet 1997;16:74-8.
3. Glode LM, Robinson J, Gould SF. Protection from cyclophosphamide-induced testicular damage with an analogue of gonadotropin-releasing hormone. Lancet 1981;i:1132-4.
4. Morris ID, Shalet SM. Protection of gonadal function from cytotoxic chemotherapy and irradiation. Ballieres Clin Endocrinol Metab 1990;4:97-118.
5. Morris ID, Bardin CW, Gunsalus G, Ward JA. Prolonged suppression of spermatogenesis by oestrogen does not preserve the seminiferous epithelium in procarbazine-treated rats. Int J Androl 1990;13:180-9.
6. Papadopoulos I. LHRH analogues do not protect the germinal epithelium during chemotherapy. Urol Res 1991;19: 31-4.
7. Morris ID, Delic JI, Hendry JH, Shalet SM. Lack of protection by oestrogen from radiation-induced testicular damage in the rat. Radiother Oncol 1988;11:83-9.
8. Nonomura M, Okada K, Hida S, Yoshida O. Does a gonadotropin-releasing hormone analogue prevent cisplatin-induced spermatogenic impairment? an experimental study in the mouse. Urol Res 1991;19:135-40.
9. Kangasniemi M, Dodge K, Pemberton E, Huhtaniemi I, Meistrich ML. Suppression of mouse spermatogenesis by gonadotropin-releasing hormone antagonist and antiandrogen: failure to protect against radiation-induced gonadal damage. Endocrinology 1996;137:949-55.
10. Dulioust E, Radigue C, Velez de la Calle JF, Jégou B, Soufir J-C, Auroux M. Traitement cytostatique chez le rat mâle: conséquences sur la descendance et effet protecteur d'un traitement hormonal préalable. C R Acad Sci Paris 1989; 309(III):137-42.
11. Glode LM, Shannon JM, Malik N, Nett T. Protection of rat spermatogenic epithelium from damage induced by procarbazine chemotherapy. Br J Cancer 1990;62:61-4.
12. Velez de la Calle JF, Jégou B. Protection by steroid contraceptives against procarbazine-induced sterility and genotoxicity in male rats. Cancer Res 1990;50:1308-15.
13. Jégou B, Velez de la Calle JP, Bauché F. Protective effect of medroxyprogesterone acetate plus testosterone against radiation-induced damage to the reproductive function of male rats and their offspring. Proc Natl Acad Sci USA 1991;88:8710-4.
14. Es-slami S, Marmor M, Soufir J-C. Genetic lesions in male gametes and cytotoxic treatments. Prevention by hormonal inhibition of spermatogenesis. In: Hamamah S, Mieusset R. Male gametes: production and quality. Paris: Les Editions INSERM, 1996:97-107.
15. Parchuri N, Wilson G, Meistrich ML. Protection by gonadal steroid hormones against procarbazine-induced damage to spermatogenic function in LBNF1 hybrid rats. J Androl 1993; 14:257-66.
16. Kurdoglu B, Wilson G, Parchuri N, Ye W, Meistrich ML. Protection from radiation induced damage to spermatogenesis by hormone treatment. Radiat Res 1994;139:97-102.
17. Meistrich ML, Wilson G, Ye W, Kurdoglu B, Parchur N, Terry N. Hormonal protection from procarbazine-induced testicular damage is selective for survival and recovery of stem spermatogonia. Cancer Res 1994;54:1027-34.
18. Kangasniemi M, Wilson G, Parchuri N, Huhtaniemi I, Meistrich ML. Rapid protection of spermatogenesis stem cells against procarbazine by treatment with a gonadotropin-releasing hormone antagonist (Nal-Glu) and an antiandrogen (flutamide). Endocrinology 1995;136:2881-8.
19. Kangasniemi M, Wilson G, Huhtaniemi I, Meistrich ML Protection against procarbazine-induced testicular damage by GnRH-agonist and antiandrogen treatment in the rat. Endocrinology 1995;136:3677-80.
20. Meistrich ML, Parchuri N, Wilson G, Kurdoglu B, Kangasniemi M. Hormonal protection from cyclophosphamide-induced inactivation of rat stem spermatogonia. J Androl 1995;16:334-1.
21. Cespedes R, Peretsman S, Thompson I, Jackson C. Protection of the germinal epithelium in the rat from the cytotoxic effects of chemotherapy by a luteinizing hormone-releasing hormone agonist and antiandrogen therapy. Urology 1995; 46:688-91.
22. Meistrich ML, Wilson G, Ye W, Thrash C, Huhtaniemi I. Relationship among hormonal treatments, suppression of spermatogenesis, and testicular protection from chemotherapy-induced damage. Endocrinology 1996;137:3823-31.
23. Brennemann W, Brensing KA, Leipner N, Boldt I, Klingmuller D. Attempted protection of spermatogenesis from irradiation in patients with seminoma by D-Tryptophan-6 luteinizing hormone-releasing hormone. Clin Invest 1994;72: 838-42.
24. Delic JI, Harwood JR, Stanley JA. Time dependence for the protective effect of androgen from procarbazine induced damage to rat spermatogenesis. Cancer Res 1987;47:1344-7.
25. Soufir J-C, Jouannet P, Marson J, Soumah A. Reversible inhibition of sperm production and gonadotropin secretion in men following combined oral medroxyprogesterone and percutaneous testosterone treatment. Acta Endocrinol 1983; 102:625-32.
26. Robb GW, Aman RP, Killian GJ. Daily sperm production and epididymal reserves of pubertal and adult rat. J Reprod Fertil 1978;54:103-7.
27. Leblond CP, Clermont Y. Definition of the stages of the cycle of the seminiferous epithelium in the rat. Ann N Y Acad Sci 1952;55:548-73.
28. Meistrich ML, van Beek MEAB. Spermatogonial stem cells: assessing their survival and ability to produce differentiated cells. In: Chapin RE, Heindel J. Methods in toxicology. Volume 3A. New York: Academic Press, Inc., 1993:106-23.
29. Delic JI, Schlappack OK, Harwood JR, Stanley JA. Comparative effects of X irradiation on the testes of adult Sprague-Dawley and Wistar rats. Radiat Res 1987;112:99-104.
30. Kangasniemi M, Huhtaniemi I, Meistich ML. Failure of spermatogenesis to recover despite the presence of A spermatogonia in the irradiated LBNF1 rat. Biol Reprod 1996;54: 1200-8.
31. Lamb IV JC. Fundamentals of male reproductive toxicity testing. In: Lamb JC IV, Foster PMD. Physiology and toxicology of male reproduction. San Diego: Academic Press, Inc., 1988:137-53.
32. Oldfield EH, Friedman R, Kinsella T, Moquin R, Olson JJ, Orr K, et al. Reduction in radiation-induced brain injury by use of pentobarbital or lidocaine protection. J Neurosurg 1990; 72:737-44.
33. Weil CS. Selection of the valid number of sampling units and a consideration of their combination in toxicological studies involving reproduction, teratogenesis or carcinogenesis. Food Cosmet Toxicol 1970;8:177-82.
34. Goodpasture JC, Bergstrom K, Vickery BH. Potentiation of the gonadotoxicity of cytoxan in the dog by adjuvant treatment with a luteinizing hormone-releasing hormone agonist. Cancer Res 1988;48:2174-8.
35. Handelsman DJ, Peng S, Sikka S, Swerdloff RS, Rajfer J. Effects of gonadotropin-releasing hormone analogs on cis-platinum-induced spermatogenic damage. Int J Androl 1988;11:425-35.
36. Grootegoed JA, Jansen R, van der Molen HJ. The role of glucose, pyruvate and lactate in ATP production by rat spermatocytes and spermatids. Biochim Biophys Acta 1984;767: 248-56.
37. Zeng H, Olive PL. Influence of oxygen on radiation-induced DNA damage in testicular cells of C3H mice. Int J Radiat Biol 1997;71:257-82.
38. Chatterjee J, De K, Basu SK, Das AK. Alteration of spermatozoal structure and trace metal profile of testis and epididymis of rat under chronic low-level X-ray irradiation. Biol Trace Elem Res 1994;41:305-19.
39. Peltola V, Parvinen M, Huhtaniemi I, Kulmala J. Comparison of effects of 0.5 and 3.0 Gy X-irradiation on lipid peroxidation and antioxidant enzyme function in rat testis and liver. J Androl 1993;14:267-74.
40. Jacobson CF, Miller MG. Species difference in 1,3-dinitrobenzene testicular toxicity: in vitro correlation with glutathione status. Reprod Toxicol 1998;12:49-56.
41. Rao B, Soufir J-C, Martin M, David G. Lipid peroxidation in human spermatozoa as related to midpiece abnormalities and motility. Gamete Res 1989;24:127-34.
42. World Health Organisation Task Force on Methods for the Regulation of Male Fertility. Contraceptive efficacy of testosterone-induced azoospermia in normal men. Lancet 1990;336:955-9.
43. Meriggiola MC, Bremner WJ, Costantino A, Di Cinto G, Flamigni C. Low dose of cyproterone acetate and testosterone enanthate for contraception in men. Hum Reprod 1998; 13:1225-9.